Clinical and scientific importance of source control in abdominal infections: Summary of a symposium

Canadian Journal of Surgery

Volumn 42, Issue 2, 1999, Pages 122-126

  Bohnen, John M A ^a,e   Marshall, John C ^a   Fry, Donald E ^b   Johnson, Steven B ^c   Solomkin, Joseph S ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYTOKINE; LYMPHOTOXIN;

ABDOMINAL INFECTION; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INFECTION CONTROL; PRACTICE GUIDELINE; SCORING SYSTEM; SURGICAL DRAINAGE;

ABDOMEN; AGED; ANTI-INFECTIVE AGENTS; CLINICAL TRIALS; HUMANS; INFECTION; MALE; MIDDLE AGED;

EID: 0032956090     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
2. Johnson SB, Albertson TE, MacArthur R, Panacek EA, Black G, Cowens JW. Impact of surgical source control on outcome from gram negative sepsis. Paper presented at the 16th annual meeting of the Surgical Infection Society, Milwaukee, Wisc., Apr. 27, 1996.
3. Nakane A, Minagawa T, Kato K. Endogenous tumor necrosis factor is essential to host resistance against Listeria monocvtogenes infection. Infect Immun 1988;56:2563-9.
4. Allendoerfer R, Magee DM, Smith JG, Bonewall L, Graybill JR. Induction of tumor necrosis factor-alpha in murine Candida albicans infection. J Infect Dis 1993;167:1168-72.
5. Alexander HR, Sheppard BC, Jensen JC, Langstein HN, Buresh CM, Venmson D, et al. Treatment of recombinant human tumor necrosis factor-alpha protects rats against the lethality hypotension and hypothermia of gram-negative sepsis. J Clin Invest 1991;8:34-9.
6. Mancilla J, Garcia P, Dinarello CA. The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats. Infect Immun 1993;61:926-32.
7. Bagby GJ, Plessaka KJ, Wilson LA, Thompson JJ, Nelson S. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis 1991;163:83-8.
8. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism with the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-4.